GENESYS BIOTECH LTD
Significant control: Genesys Biotech Eot Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Genesys Biotech Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Genesys Biotech Ltd sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
GENESYS BIOTECH LTD is an active private limited company (company number 04603049) incorporated on 27 November 2002, registered in London. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest small accounts cover the period ending 31 March 2025, showing net assets of £11.05m and cash of £9.35m, with 13 employees on average. Net assets fell 65% on the prior period (£31.24m).
By net assets it sits in the top quarter of 654 comparable companies in London (median £101, upper quartile £41k).
Ownership and control
- Genesys Biotech Eot Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dr Duncan Roy Clark
- has significant influence or control
- Dr Nicholas Richard Morant
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mrs Sarah Louise Dugdale
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 27 November 200223 yrs ago
- Next accounts due
- 31 December 2026in 67 days
- Confirmation statement due
- 11 December 2026in 47 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £11.05m | £9.35m | £994k | — | — | — | 13 |
| 31 March 2024 | £31.24m | £30.52m | £669k | — | — | — | 11 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £11,048,262 at 31 March 2025
- Net assets down 25% or more on the prior period-64.6% vs prior period
- Cash at bank of £50,000 or moreCash £9,348,126
- Incorporated five or more years agoIncorporated 27 November 2002
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 67 days
- Confirmation statement duein 47 days
- Accounts period endNet assets £11.05m · small accounts
- Accounts period endNet assets £31.24m · small accounts
- Incorporated
Similar companies in London
- VISICOMP RESEARCH LIMITEDinc. Dec 2002
- ANCON TECHNOLOGIES LIMITEDLondon · inc. Jan 2003
- HEMOCORM LIMITEDLondon · inc. Jan 2003
- AMBIENT MEDIA WORLDWIDE LTDHammersmith · inc. Sept 2002
- TECHNO-PRO LTDinc. Jan 2003
- GARRAD HASSAN GROUP LIMITEDLondon · inc. Feb 2003
All companies incorporated on 27 November 2002 · in Nov 2002.
Reminders for GENESYS BIOTECH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.